Mucin 5AC (MUC5AC) Mouse Monoclonal Antibody [Clone ID: MRQ-19]

CAT#: TA327703

Mouse Monoclonal MUC 5AC Antibody



Need it in bulk or conjugated?
Get a free quote

CNY 7,481.00


货期*
5周

规格
    • 1 ml

Cited in 1 publication.

Product images

经常一起买 (1)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00

Specifications

Product Data
Clone Name MRQ-19
Applications IHC
Recommend Dilution IHC: 1:100 - 1:500
Reactivity Human
Host Mouse
Clonality Monoclonal
Formulation This antibody is supplied as cell culture supernatant diluted in tris buffered saline, pH 7.3-7.7, with 1% BSA and <0.1% sodium azide.
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Gene Name mucin 5AC, oligomeric mucus/gel-forming
Synonyms gastric; gastric mucin; gel-forming; MUC5; mucin 5; mucin 5AC; oligomeric mucus; subtypes A and C; tracheobronchial; tracheobronchial mucin
Note Mucins are high molecular weight glycoproteins which constitute the major component of the mucus layer that protects the gastric epithelium. The heterogeneous pattern of mucin expression, including the expression of the intestinal mucin MUC2, may provide new insights into the differentiation pathways of gastric carcinoma. Pinto-de-Sousa et al. have shown, in a comprehensive study of gastric carcinomas evaluated for expression of several mucins (MUC1, MUC2, MUC5AC and MUC6), that: (1) mucin expression is associated with tumor type (MUC5AC with diffuse and infiltrative carcinomas and MUC2 with mucinous carcinomas) but not with the clinico-biological behavior of the tumors; and (2) mucin expression is associated with tumor location (MUC5AC with antrum carcinomas and MUC2 with cardia carcinomas), indirectly reflecting differences in tumor differentiation according to tumor location. The following generalities apply to the patterns of MUC5AC expression: Preferentially expressed in the normal stomach and respiratory tract; esophageal carcinomas – 67%, gastric carcinomas – 58%, colonic carcinomas – 6%-25%, pancreatic ductal carcinomas – 73%, cholangiocarcinomas – 45%, endocervical adenocarcinomas – 70%, endometrial adenocarcinomas – 22%, and lung adenocarcinomas – 14%.
Reference Data
Protein Families Druggable Genome
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Citations (1)

Customer Reviews 
Loading...